非小细胞肺癌微波消融术后血清Caspase-4变化及意义

doi:10.3877/cma.j.issn.1674-6902.2020.02.019

目的

探讨非小细胞肺癌(NSCLC)患者微波消融术后血清半胱天冬酶(Caspase-4)变化及意义。

方法

选择2013年3月至2016年1月我院及省肿瘤医院收治的159例NSCLC患者作为研究对象，所有患者均接受微波消融治疗。采用活性荧光法测定检测NSCLC患者微波消融治疗前后血清Caspase-4水平。比较不同预后NSCLC患者血清Caspase-4水平。采用受试者工作特征(ROC)曲线分析血清Caspase-4评估NSCLC患者预后的价值。比较不同血清Caspase-4水平NSCLC患者平均生存时间，并采用Cox单因素及多因素分析影响NSCLC患者预后的相关因素。

结果

NSCLC患者微波消融术后血清Caspase-4水平明显低于术前，差异有统计学意义(3.51±0.82)ng/ml vs. (4.33±0.96)ng/ml，P<0.05。死亡组NSCLC患者血清Caspase-4水平高于生存组，差异有统计学意义(5.01±0.63)ng/ml vs. (3.04±0.47)ng/ml，P<0.05。微波消融术后血清Caspase-4评估NSCLC患者预后的AUC、敏感度、特异性分别为0.851、65.79%、90.91%。Caspase-4≥3.17 ng/ml的NSCLC患者平均生存时间明显低于Caspase-4<3.17 ng/ml的NSCLC患者，差异有统计学意义30.19(95%CI：27.84～32.49)个月vs. 33.19(95%CI：31.77～34.60)个月，P<0.05。Cox单因素分析显示年龄、病理类型、分化程度、TNM分期、淋巴结转移、Caspase-4水平与NSCLC预后可能有关(P<0.05)，进一步Cox多因素回归分析显示TNM分期、淋巴结转移、Caspase-4水平与NSCLC患者预后密切相关(P<0.05)。

结论

微波消融术后NSCLC患者血清Caspase-4水平明显降低，血清Caspase-4水平与NSCLC患者预后密切相关，检测术后血清Caspase-4水平对于评估NSCLC患者预后具有重要临床意义。

关键词: 非小细胞肺癌, 微波消融术, 血清半胱天冬酶-4, 预后

Objective

To investigate the changes and significance of serum cysteinyl aspartate specific proteinase-4 (Caspase-4) in patients with non-small cell lung cancer (NSCLC) after microwave ablation.

Methods

One hundred and fifty-nine patients with NSCLC admitted to our hospital and Provincial Cancer Hospital from March 2013 to January 2016 were selected as the subjects of study. All patients received microwave ablation. Serum Caspase-4 levels were measured by active fluorescence method in patients with NSCLC before and after radiofrequency ablation. Serum Caspase-4 levels in NSCLC patients with different prognosis were compared. The prognostic value of serum Caspase-4 in patients with NSCLC was analyzed by ROC curve. The mean survival time of NSCLC patients with different serum Caspase-4 levels was compared. Cox single factor and multi-factor analysis were used to analyze the related factors affecting the prognosis of patients with NSCLC.

Results

The serum Caspase-4 level of NSCLC patients after microwave ablation was significantly lower than that before operation, and the difference was statistically significant [(3.51±0.82) ng/ml vs. (4.33±0.96) ng/ml, P<0.05]. The serum Caspase-4 level of NSCLC patients in death group was significantly higher than that in survival group, and the difference was statistically significant [(5.01±0.63) ng/ml vs. (3.04±0.47) ng/ml, P<0.05]. The AUC, sensitivity and specificity of serum Caspase-4 in evaluating the prognosis of NSCLC patients after microwave ablation were 0.851, 65.79% and 90.91%, respectively. The average survival time of NSCLC patients with Caspase-4≥3.17 ng/ml was significantly lower than that of NSCLC patients with Caspase-4<3.17 ng/ml, and the difference was statistically significant [30.19 (95%CI: 27.84~32.49) months vs. 33.19 (95%CI: 31.77~34.60) months, P<0.05]. Cox univariate analysis showed that age, pathological type, degree of differentiation, TNM stage, lymph node metastasis, Caspase-4 levels might be related to the prognosis of NSCLC (P<0.05). Further Cox multivariate regression analysis showed that the TNM stages, lymph node metastasis and Caspase-4 were closely related to the prognosis of NSCLC patients (P<0.05).

Conclusion

The serum Caspase-4 level was significantly decreased in NSCLC patients after microwave ablation. The serum Caspase-4 level was closely related to the prognosis of NSCLC patients. Detecting the serum Caspase-4 level after microwave ablation has important clinical significance for evaluating the prognosis of NSCLC patients.

Key words: Non-small cell lung cancer, Microwave ablation, Serum cysteinyl aspartate specific proteinase-4, Prognosis

图1 血清Caspase-4评估患者预后的ROC曲线

图2 Caspase-4≥3.17 ng/ml及Caspase-4<3.17 ng/ml NSCLC患者生存曲线

表1 影响NSCLC患者预后的相关因素

临床资料	Cox单因素			Cox多因素
临床资料	HR	95%CI	P值	HR	95%CI	P值
性别(男/女)	1.358	0.873～1.827	0.146	-	-	-
年龄(≥60/<60岁)	2.384	1.046～4.277	0.042	1.738	0.951～2.591	0.077
病理类型(鳞癌/腺癌/腺鳞癌)	2.278	1.016～3.830	0.049	1.560	0.846～2.153	0.085
淋巴结转移(有/无)	2.595	1.104～5.210	0.038	2.285	1.020～3.447	0.048
分化程度(低分化/高分化)	3.204	1.231～5.883	0.031	2.535	1.074～4.827	0.039
TNM分期(Ⅲ～Ⅳ/Ⅰ～Ⅱ)	3.629	1.337～7.021	0.020	2.220	1.219～3.530	0.051
Caspase-4(≥3.17/<3.17 ng/ml)	4.105	1.439～7.492	0.014	3.683	1.332～6.50	0.022

表1 影响NSCLC患者预后的相关因素

临床资料	Cox单因素			Cox多因素
临床资料	HR	95%CI	P值	HR	95%CI	P值
性别(男/女)	1.358	0.873～1.827	0.146	-	-	-
年龄(≥60/<60岁)	2.384	1.046～4.277	0.042	1.738	0.951～2.591	0.077
病理类型(鳞癌/腺癌/腺鳞癌)	2.278	1.016～3.830	0.049	1.560	0.846～2.153	0.085
淋巴结转移(有/无)	2.595	1.104～5.210	0.038	2.285	1.020～3.447	0.048
分化程度(低分化/高分化)	3.204	1.231～5.883	0.031	2.535	1.074～4.827	0.039
TNM分期(Ⅲ～Ⅳ/Ⅰ～Ⅱ)	3.629	1.337～7.021	0.020	2.220	1.219～3.530	0.051
Caspase-4(≥3.17/<3.17 ng/ml)	4.105	1.439～7.492	0.014	3.683	1.332～6.50	0.022

1	钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
2	徐　莉，朱晔涵. 血清CA125和IL-10水平测定在评估晚期非小细胞肺癌患者预后中的价值[J]. 临床肺科杂志，2016, 21(4): 616-619.
3	Bhansing KJ, Van Riel PLCM, Van Engelen BGM, et al. Patients with systemic sclerosis/polymyositis overlap have a worse survival rate than patients without it[J]. J Rheumatol, 2016, 43(10): 1838-1843.
4	Deneka AY, Leora H, Kopp MC, et al. Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model[J]. Plos One, 2017, 12(4): e0176747.
5	Christoph Pöttgen, Eberhardt W, Stamatis G, et al. Definitive radiochemotherapy versus surgery within multimodality treatment in stage Ⅲ non-small cell lung cancer (NSCLC)- a cumulative meta-analysis of the randomized evidence[J]. Oncotarget, 2015, 8(25): 41670-41678.
6	高映浩，侯恩存，甘　川. 非小细胞肺癌EGFR-TKI获得性耐药后治疗策略的研究进展[J]. 现代肿瘤医学，2018, 26(14): 2285-2289.
7	Wei Z, Ye X, Yang X. Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations[J]. Oncotarget, 2017, 8(34): 56714-56725.
8	Zheng A, Ye X, Yang X, et al. Local efficacy and survival after microwave ablation of lung tumors: a retrospective study in 183 patients[J]. J Vasc Interv Radiol, 2016, 27(12): 1806-1814.
9	胡　娟. 超声引导经皮穿刺微波消融治疗甲状腺肿瘤的护理[J]. 中国冶金工业医学杂志，2017, 34(1): 43-44.
10	Terlizzi M, Colarusso C, De IR, et al. Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer[J]. Oncotarget, 2018, 9(27): 19356-19367.
11	李仁琴，陈晓品. HGF/c-MET抑制剂在晚期非小细胞肺癌中的治疗进展[J]. 临床肺科杂志，2017, 22(4): 718-722.
12	Fleckenstein J, Kremp K, Kremp S, et al. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.[J]. Strahlenthe Onkol, 2016, 192(2): 75-82.
13	高惜惜，尤青海，孙耕耘. 中性-淋巴比和预后营养指数与非小细胞肺癌患者预后的相关性研究[J/CD]. 中华肺部疾病杂志(电子版), 2016, 9(2): 125-130.
14	魏朋华，沈志鹏，王　华，等. 3项指标在非小细胞肺癌组织中的表达及其与患者预后的相关性研究[J]. 国际检验医学杂志，2017, 38(16): 2243-2245,2248.
15	Ma J, Zhao Z, Wu K, et al. MCL-1 is the key target of adjuvant chemotherapy to reverse the cisplatin-resistance in NSCLC[J]. Gene, 2016, 587(2): 147-154.
16	乔晓媛，牛润桂，王利芳. 放化疗联合治疗对局部晚期非小细胞肺癌患者疗效的评价[J]. 中国药物与临床，2015, 15(7): 998-1000.
17	Zhang K, Yu J, Yu X, et al. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma[J]. Int J Hyperthermia, 2018, 34(3): 292-297.
18	Vogl TJ, Qian J, Tran A, et al. Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats[J]. Diagn Interv Radiol, 2017, 23(2): 150-155.
19	杨　荣，李友健，刘天遥，等. 肾动脉低温灌注联合机器人辅助冷循环射频消融治疗复杂性肾脏肿瘤[J]. 临床泌尿外科杂志，2018, 294(6): 11-14.
20	姜彬彬，张仲一，严　昆，等. 经皮超声引导下射频消融治疗胃癌肝转移疗效分析[J]. 中国介入影像与治疗学，2018, 15(1): 24-28.
21	Kang SJ, Lee YJ, Kang SG, et al. Caspase-4 is essential for Saikosaponin a-induced apoptosis acting upstream of caspase-2 and γ-H2AX in colon cancer cells[J]. Oncotarget, 2017, 8(59): 100433-100448.
22	李元滨. 益气除痰法通过caspase-4途径抗癌及中西医联合治疗晚期NSCLC miRNA表达谱初步研究[D]. 广州中医药大学，2014: 12-24.
23	Camacho Romero J, Oliver Goldaracena, José María, et al. CT-guided radiofrequency ablation of non-small cell lung cancer[J]. Med Clín (Barc), 2010, 135(13): 581-585.
24	方　勇，倪旭东. 射频消融术治疗肺部肿瘤的临床研究[J]. 中国临床医学，2012, 19(6): 619-621.
25	Jazieh AR, Hussain M, Howington JA, et al. Prognostic factors in patients with surgically resected stages Ⅰ and Ⅱ non-small cell lung cancer[J]. Ann Thoracic Surg, 2000, 70(4): 1168-1171.
26	Vargas SO, Leslie KO, Vacek PM, et al. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: Pathologic and prognostic correlations[J]. Cancer, 1998, 82(8): 1495-1500.
27	李爱武，徐建芳，朱　韧，等. 两种因素对晚期NSCLC患者预后的影响[J]. 同济大学学报：医学版，2009, 30(4): 77-81.
28	Huang CI, Taki T, Higashiyama M, et al. p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung[J]. Br J Cancer, 2000, 82(2): 374-380.
29	宋　朋，臧若川，张默言，等. ⅠB期非小细胞肺癌术后预后因素分析[J]. 中华肿瘤杂志，2017, 39(4): 293-297.
30	Hitomi J, Katayama T, Eguchi Y, et al. Involvement of Caspase-4 in endoplasmic reticulum stress-induced apoptosis and a-induced cell death[J]. J Cell Biol, 2004, 165(3): 347-356.
31	Sollberger G, Strittmatter GE, Kistowska M, et al. Caspase-4 is required for activation of inflammasomes[J]. J Immunol, 2012, 188(4):1992-2000.

[1]	李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[2]	张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[3]	马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[4]	杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[5]	栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[6]	江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[7]	晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[8]	鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[9]	姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗：10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[10]	钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[11]	萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[12]	胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[13]	李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14]	王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15]	索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Changes and significance of serum Caspase-4 in patients with non-small cell lung cancer after microwave ablation

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Changes and significance of serum Caspase-4 in patients with non-small cell lung cancer after microwave ablation